Company intelligence / Profile preview

Bluebird Ventures

Palo Alto, California, USAbluebirdvc.com ↗

Ownership: Private
Development stage: Other

Overview

Bluebird Ventures is a venture capital fund focused on creating and investing in life sciences companies with the potential for significant global impact. Founded by Jeff Bird and managed in association with Sutter Hill Ventures, the firm supports innovative startups across biotechnology, gene therapy, immuno-oncology, medical devices, and RNA therapeutics. Its portfolio includes companies at various clinical stages from preclinical to commercial.

Therapeutic areas: CardiovascularOphthalmologyEndocrinologyOncologyNeurology
Modalities: Small moleculeMonoclonal antibodyGene therapyPeptide-based cytokine activatormRNA-based drugs/RNA therapeuticsDevice
Industry: Investors

Partnerships

Forty Seven’s acquisition by Gilead ($4.9B)Collaborations between Nutcracker Therapeutics and other biotech/pharma firms

Beyond the preview

Go deeper on Bluebird Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bluebird Ventures.

Explore the full profile